Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 478Carcinoma, Non-Small-Cell Lung 436Prostatic Neoplasms 277Lung Neoplasms 169Stomach Neoplasms 138Neoplasms 112Squamous Cell Carcinoma of Head and Neck 108Head and Neck Neoplasms 96Neoplasm Metastasis 92Esophageal Neoplasms 70Ovarian Neoplasms 56Pancreatic Neoplasms 41Sarcoma 39Urinary Bladder Neoplasms 38Nasopharyngeal Carcinoma 32Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 25Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

pertuzumab 2Paclitaxel 2Neoadjuvant Therapy 2Docetaxel 2Carboplatin 2pyrotinib 1pegfilgrastim 1Trastuzumab 1Mastectomy, Modified Radical 1Letrozole 1Hydralazine 1Doxorubicin 1Cyclophosphamide 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Breast Cancer × Docetaxel × Clear all
NCT03329378 2023-08-22

Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Terminated
7 enrolled 10 charts
Breast

Locally Advanced Breast Cancer

NCT01660542 2016-11-01

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

Yonsei University

Phase 4 Completed
96 enrolled
Breast

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡